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ABSTRACT
The effects of the trypanocidal drugs against Trypanosoma evansi isolated from Philippine water buffaloes 
from the three island groups were comparatively evaluated. Specifi cally, the study determined the duration of 
the effi cacy, relapse and death per drug dosage using laboratory mice. A total of 270 inbred Balb/c mice were 
divided into three groups corresponding to the three trypanosome isolates (Luzon, Visayas, and Mindanao). 
Each group had three sets, corresponding to the three trypanocidal drugs used with fi ve treatment levels, and 
one control group each. Each experimental group was composed of fi ve mice. Each mouse was inoculated 
with 0.2 mL of T. evansi intraperitoneally and blood was examined under the microscope. Parasitemia level 
was determined using the “Rapid Matching Method”. Effective and curative doses were noted and evaluated 
through t-test and bio-assay graphical analyses. Results showed that the Luzon isolate was sensitive to >5 mg/
kg of diminazene diaceturate and >10 mg/kg of both isometamidium chloride and quinapyramine sulphate + 
chloride. The Visayas isolate was sensitive to >5 mg/kg, >10 mg/kg, and >3 mg/kg of diminazene diaceturate, 
isometamidium chloride and quinapyramine sulphate + chloride, respectively. The Mindanao isolate was 
sensitive to >3 mg/kg of diminazene diaceturate and quinapyramine sulphate + chloride and 20 mg/kg of 
isometamidium chloride. The study suggested diminazene as the recommended drug against Luzon isolates, 
quinapyramine against Visayas isolates and either diminazene or quinapyramine against Mindanao isolates.
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Introduction
Surra is an important disease of farm animals such as cattle and water buffaloes in the 
Philippines. In 1990-1998, it produced economic losses amounting to P44.8 million (US$ 
1.15 million) due to death, excluding losses from reduced reproductive performance, 
milk yield, loss of weight, and draught power, which are likely to be substantially greater 
(MANUEL, 1998; VENTURINA et al., 2008).
Surra has been reported to be endemic in the three major island groups in the 
Philippines. Recently, a study showed differing virulence of the three Trypanosoma 
evansi (T. evansi) isolates in the country, tagged as Luzon, Visayas and Mindanao isolates 
(VERDILLO et al., 2012). It was then hypothesized that the diversity of the three isolates 
might also result in a difference in drug response. Numerous drug treatments have been 
tested over the years, but have not been widely adopted because of various problems 
associated with their effi cacy, availability, toxicity and/or affordability (VENTURINA 
et al., 2008). In the Philippines, the commonly used trypanocidal drugs are naganol, 
diminazene, suramin, isometamidium, quinapyramine and cymelarsan (VENTURINA et 
al., 2008). 
Sensitivity to trypanocidal drugs means effectiveness against the target protozoa. 
However, prolonged use of these agents may lead to the development of resistance. 
Determination of trypanocidal sensitivity or resistance of trypanosomes isolated in water 
buffaloes per island group will help veterinarians for better management and strategic 
treatment of Surra in the country.
The objective of the present study was to compare trypanocidal effects of selected 
drugs against T. evansi isolated from Philippine water buffaloes, representing the three 
different island groups.
Materials and methods
Two hundred seventy (270) Balb/c mice (7-8 weeks of age and weighing about 25 to 
30 grams) were used and divided into three groups corresponding to the three trypanosome 
isolates (Luzon, Visayas, and Mindanao). Each group had three set-ups, corresponding to 
the three drugs, 7% diminazene diaceturate (Sequent, India), 2% isometamidium chloride 
(Merial, France) and 16.7% quinapyramine sulphate and chloride (Cipla, India), with fi ve 
mice per treatment and control groups.
The experiment conforms to the guidelines for care and use of laboratory animals, 
published by the US National Institute of Health (NIH Publication no. 85-23, revised 1996)
Viability testing. Blood with trypanosomes was preserved at -80 ºC as a 1:1 mixture 
with bicine buffered saline (bbs) solution (pH 8.0) plus 20% w/v of glycerol and 10% v/v 
heparin. Samples were taken from the deep freezer and thawed in a water bath (37 °C 
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for 15 minutes). A motility test for the protozoa was undertaken by placing a tuberculin 
syringe-aspirated drop-sized blood sample, of suffi cient quantity to spread and cover the 
entire interface between a glass slide and a 24 × 24 mm cover slip. It was examined under 
40 × 10 magnifi cation. 
Quantifi cation of trypanosomes. If they were motile, 0.2 mL was inoculated 
intraperitoneally per mouse per isolate. Three days post-inoculation, a small drop of 
blood was collected from the tail of the inoculated mouse and placed on a glass slide, with 
a 24 × 24 mm coverslip, and examined under 40 × 10 magnifi cation. If the parasitemia 
level of the inoculated mouse attained a log of 9.0, the mouse was sacrifi ced and 1 mL 
of blood was collected intracardiac using tuberculin syringe. The collected blood was 
placed in a microcentrifuge tube and diluted by adding a drop of bbs. After every addition 
of bbs, the sample was mixed gently. Dilution was stopped only when 32 trypanosomes 
per fi eld (log of 8.1) were attained. This corresponds to 126,000,000 trypanosomes per 
1.0 mL dilution (HERBERT and LUMSDEN, 1976). The experimental inoculum size of 
0.2 mL was estimated to contain 25,200,000 organisms. Preserved cultures with the fi rst 
and second passages were used in the study. Passage in the mice was restricted to two to 
three times, in order to minimize selection of sub-populations from the original isolates 
(EISLER et al., 2001).
Inoculation of trypanosomes, drug regimen and checking the parasitemia. On the 
fi rst day, each experimental mouse was weighed prior to the designation of markers and 
dosage computations and the prepared 0.2 mL sample was inoculated by intraperitoneal 
route (IP). At 24 hours post-inoculation (2nd day), parasitemia in tail blood was checked 
from each experimental animal.
Drug injection was by IP route, each treatment group received the desired dosage 
regimen (the weight of the animal multiplied by the experimental dose and divided by 
the drug concentration), while the control groups received 0.2 mL distilled water, on the 
same occasion. The fi ve treatments were as follows: 1 mg/kg, 3 mg/kg, 5 mg/kg, 10 mg/
kg and 20 mg/kg for diminazene and isometamidium, and 15 mg/kg for quinapyramine. 
The computed dose was diluted with 0.2 mL distilled water in a microcentrifuge tube 
before it was injected intraperitoneally. 
Parasitemia was checked at 12, 24, 48 and 72 hours post-treatment and subsequently 
twice a week until the end of a 60-day observation period. The number of days from the 
fi rst detection and description of parasitemia was recorded. Charts and tables from the 
rapid matching method for estimating parasitemia by HERBERT and LUMSDEN (1976) 
were used in the study.
Animal identifi cation. Body markings and codes were made to avoid errors in data 
recording and ensure accurate and comprehensive analysis. Different anatomical areas 
were coded by applying picric acid solution using dipsticks with cotton.
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Data interpretation. The number of cured animals was used for interpretation of 
the results. Curative Dose 80 and 100 (CD80; CD100) indicated that the drug dosage was 
effective if at least four out of the fi ve treated mice were cured after the period of 60 days. 
Hence, the isolates treated were said to be sensitive. If fewer than four mice were cured 
(CD60, CD40, CD20, or CD0), the drug dosage was ineffective. Hence the isolate treated 
was said to be tolerant (EISLER et al., 2001). The use of fi ve mice per group allowed an 
easy calculation of the values (SONES et al., 1988).
Data analyses. Comparisons of effective dose and curative dose values were done 
using bio-assay graphical analysis. T-test was used to compare the difference between the 
mean days of death from the control group against non-curative drug dosage.
Results
Effects of the three trypanocidal drugs against the different isolates. The effects of 
each drug dosage varied among the three trypanosome isolates. The result shows that the 
higher drug dosages were curative.
The effects of the three trypanocidal drugs against the three trypanosome isolates are 
shown in Fig. 1. Luzon isolates were sensitive at 5 mg/kg with CD100 in diminazene, and 
at 10 mg/kg with CD100 and CD80 in isometamidium, and quinapyramine, respectively. 
Fig. 1. Bio-assay graphical analysis comparing the different trypanocidal dosages with CD80  and 
CD100 after 60 days against T. evansi isolated from Philippine water buffaloes
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Fig. 2. Bio-assay graphical analysis comparing the onset of death after relapse per drug dosage in 
(A) Luzon, (B) Visayas, and (C) Mindanao isolates
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Visayas isolates were sensitive beginning at 5 mg/kg with CD80 in diminazene, at 10 mg/
kg with CD100 in isometamidum and at 3 mg/kg with CD100 in quinapyramine. Mindanao 
isolates were sensitive beginning at 3 mg/kg with CD100 in diminazene, at 20 mg/kg with 
CD100 in isometamidium and at 3 mg/kg with CD80 in quinapyramine.
Evaluation of the drug dosage that showed relapse and death using the curative dose 
(CD) values. Fig. 2-A shows the onset of death after relapse per dosage in Luzon isolates. 
In diminazene, T1 and T2 showed CD0 at mean of Day 12 and 23.75, respectively. The 
latter was highly signifi cant compared to the control groups (P<0.0000 at P<0.05). In 
isometamidium, T1, T2 and T3 showed CD0, CD20, and CD60 days at mean of Days 10.6, 
11 and 13, respectively. In quinapyramine, T1, T2 and T3 showed CD20, CD0, and CD20 at 
Days 30.5, 26 and 32, respectively. 
The onset of death after relapse per dosage in Visayas isolates is shown in Fig. 2-B. 
In diminazene, T1 and T2 showed CD0 and CD60 days at mean of Days 13.6 and 22, 
respectively. In isometamidium, T1, T2 and T3 showed CD40 (both T1 and T3), and CD20 
at Days 19, 32.7 and 53.3, respectively. In quinapyramine, T1 showed CD20 at Day 21. 
Fig. 2-C shows the onset of death after relapse per dosage in Mindanao trypanosome 
isolates. In both diminazene and quinapyramine, T1 showed CD20 and CD60 days at 
mean days 24.5 and 35, respectively. In isometamidium, T1, T2, T3 and T4 showed 
CD0 (both T1 and T3) and CD20 (both T2 and T4) at days 5.8, 24.5, 18.60 days, and 
32.75, respectively. However, onset of death was not signifi cant in T1 (P<1.0000) and T2 
(P<0.1002) while highly signifi cant at T3 (P<0.0045) to T4 (P<0.0017) compared to the 
control group (signifi cantly different at P<0.05).
Discussion
The isolates in this study were obtained from infected water buffaloes in different areas 
that had received no trypanocidal treatment. Drug effi cacy and failure to treat a certain 
disease are infl uenced by numerous factors. The results obtained could be infl uenced 
by some mechanisms concerning the drugs, the parasites, and the hosts (GEERTS and 
HOLMES, 1998).
One factor that could infl uence the results are the different modes of action of the 
trypanocidal drugs against the target parasites. Diminazene disrupts the phosphoglycerate 
synthesis by binding to the DNA (ADAMS, 1995; MEDINA, 2008). The drug selectively 
blocks the replication of kinetoplast DNA (MAMMAN et al., 1994). Isometamidium 
cleaves the kinetoplast DNA topoisomerase complexes. The trypanosome kinetoplast is 
the primary site of isometamidium accumulation (GEERTS and HOLMES, 1998; ANONYM., 
2008). It inhibits DNA- primed RNA polymerase as a result of intercalation of the drug 
with DNA. This causes local unwinding and lengthening of the DNA helix and thus 
interferes with its function as a primer in nucleic acid synthesis (ADAMS, 1995; MEDINA, 
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2008). Quinapyramine targets protein synthesis by kDNA condensation with extensive 
loss of ribosomes (MEHLHORN, 2008).
The three drugs target the kinetoplast of the organism. However, some studies have 
reported the absence of kinetoplast in some strains of T. evansi. These dyskinetoplastic 
forms were found in wild strains that have undergone mutation, isolated from animals 
that received treatment with trypanocides (BRUN et al., 1998; ZWEYGARTH et al., 
1990). This was also observed by JUYAL (Newer perspective in the diagnosis and control of 
Trypanosomosis (Surra) in domestic livestock in India, 2002) in his study, that dyskinetoplastic 
forms of T. evansi appear after treatment with a variety of trypanocidal drugs, including 
diminazene and pyrithidium. Therefore, relapse of infection by the organisms could 
occur because the drugs were not able to target the relevant anatomical part and death 
occurred in the mice. In cases where resistance is not a problem, one possible reason for 
relapse could be attributed to the inaccessibility of the drugs to reach the tissue stages of 
trypanosomes (JENNINGS et al., 1977; AL-MOHAMMED, 2008). Trypanosomes reside in 
the blood vessels of all organs, in the extravascular spaces of the brain, and the interstitial 
tissues of the lungs and testes (SUDARTO et al., 1990). Among these structures, the brain 
is the site where diminazene in particular was not able to penetrate (PEREGRINE and 
MAMMAN, 1993). This could be the reason why some trypanosomes escaped from the 
trypanocidal action of diminazene, in which relapse of infection is possible. This fi nding 
is also observed in the case of Trypanosoma brucei infection after relapse had occurred 
from a privilege site inaccessible to the diminazene (MAMMAN et al., 1994; ONYEYILI and 
EGWU, 1995; NWIYI et al., 2006).
Extensive use of the limited number of commercially available trypanocides has 
resulted in the appearance of trypanosome strains resistant to the drugs (MBWAMBO et al., 
1988; JENNINGS, 1990; FAIRLAMB, 1991; ELRAYAH and KAMINSKY, 1991; ZHANG et al., 
1993). It could be that isometamidium was one of the frequently used anti-trypanosomes 
in the Mindanao area. As the results revealed, the drug needed the highest dosage (20 
mg/kg) to cure the mice infected with trypanosome isolated from the island, as compared 
to the curative dosage (10 mg/kg) needed against trypanosome isolated from Luzon and 
Visayas islands. Diminazene was also used in the country and traded under different 
names. Based on the results, the drug needed a 10 mg/kg dosage to cure infected mice, 
which is higher in comparison with the recommended dosage of 3.5 mg/kg in large 
animals. This could be the reason why some reports stated that one or two replication 
sites revealed T. evansi isolates to be resistant, from the three provinces in Visayas, such 
as Northern Samar (83.3%), Leyte (6.6%) and Biliran (100%) in which diminazene has 
been used for more than nine years (VENTURINA et al., 2008).
Dosages that were found curative in this study could be compared to the reports made 
by ZHANG et al. (1991). The T. evansi used by the latter was taken from infected horses 
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in 1982 and was not isolate specifi c. They observed that it was sensitive at 9 mg/kg in 
diminazene, which is in the range of the drug’s curative dosage, from 3 to 20 mg/kg based 
on the results. In isometamidium, they observed that a dosage of more than 20 mg/kg was 
needed, while 10 to 20 mg/kg were already curative in this study. In quinapyramine, it 
was found that a dosage at 1.25 mg/kg was already curative in the mice. But, the results 
of this study showed that higher dosages from 3 to 15 mg/kg were needed to eliminate 
the trypanosomes.
The effects of these trypanocidal drugs were also studied. Diminazene failed to control 
infection in 20% of mice separately infected with two Mindanao isolates (DARGANTES, 
2010). Isometamidium given intraperitoneally at dose rates ranging from 2-15 mg/kg 
body mass provided weak chemotherapeutic activity in cats experimentally infected with 
the Philippine strain of T. evansi, as studied by MANUEL (1985). A quinapyramine dose 
rate of 1 mg/kg was able to cure all four mice used in the experiments (GILLINGWATER 
et al., 2009).
Relapse of infection and death were also seen by some authors in their experiments. 
DARGANTES (2010) claimed that treatment with diminazene was found to be ineffective 
because relapse occurred on the 27th day post-treatment when used in rats and goats. 
DIVINA (2004) reported a reoccurrence of parasitemia in mules and horses after fi ve days 
of treatment in severely parasitized animals. Preliminary studies at Central Mindanao 
University showed that diminazene diaceturate (the standard treatment for Surra in the 
Philippines) did not cure T. evansi infection in goats when a single dose of 7 mg/kg was 
given (REID, 2001).
The results were comparative with the recommended dosages used to treat Surra 
in large animals. Diminazene is recommended at a dosage of 3.5 mg/kg. In the study, 5 
mg/kg was needed to cure infection by Luzon and Visayas isolates, but 3 mg/kg against 
Mindanao isolates. Isometamidium is recommended at 0.25 to 0.50 mg/kg. In the study, 
10 mg/kg was needed to cure infection against Luzon and Visayas isolates, but 20 mg/kg 
against Mindanao isolates. Quinapyramine is recommended at a dose rate of 4.4 mg/kg 
dose rate. Meanwhile, 10 mg/kg was needed to cure infection by Luzon isolate while 3 
mg/kg against Visayas and Mindanao isolates.
Conclusion
The effects of the three trypanocidal drugs (7% diminazene diaceturate, 2% 
isometamidium chloride, 16.7% quinapyramine sulphate + chloride) varied among the 
three Philippine water buffaloes Trypanosoma evansi isolates (Luzon, Visayas, and 
Mindanao) in murine model. Based on the fi ndings, the study suggests diminazene as the 
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recommended drug against Luzon isolates, quinapyramine against Visayas isolates and 
either diminazene or quinapyramine against Mindanao isolates.
The determined minimum curative doses in experimental mice did not exceed the 
dose rates indicated for large animals. Except for the 2% isometamidium chloride, in 
which the recommended dosage at 1 mg/kg is no longer effective against the Mindanao 
isolate. The dose should be increased to 2 mg/kg.
Moreover, it is suggested that a continuous study should be conducted to investigate 
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SAŽETAK
Istraženi su učinci tripanocidnih lijekova na izolate vrste Trypanosoma evansi izdvojene iz triju 
otočnih skupina fi lipinskih vodenih bivola. Određivano je trajanje učinkovitosti, pojava recidiva i uginuća u 
laboratorijskih miševa. Ukupno je 270 miševa Balb/c bilo podijeljeno u  u tri skupine što je bilo sukladno 
trima izolatima s tri  fi lipinska otoka i to Luzon, Visayas i Mindanao. Svaka skupina bila je podijeljena u tri 
podskupine koje su peterokratno dobivale tri različita lijeka. Unutar svake skupine određena je i kontrolna 
podskupina. U svakoj pokusnoj skupini bilo je pet miševa. Svakom mišu bila su intraperitonejski ubrizgana 
0,2 mL kulture T. evansi i izvađena krv za mikroskopsku pretragu. Razina parazitemije određivana je brzom 
metodom (engl. rapid matching method). Učinkovitost i ljekovita doza vrednovane su t-testom i grafi čkom 
analizom biološkog pokusa. Rezultati su pokazali da  je izolat Luzon  bio osjetljiv na 5 mg/kg diminazenova 
diaceturata i 10 mg/kg izometamidijeva klorida i kombinacije kvinapiramin sulfata i klorida. Izolat Visayas 
bio je osjetljiv na 5 mg/kg diminazen diaceturata,  10 mg/kg izometamidij klorida i 3 mg/kg kombinacije 
kvinapiramin sulfata i klorida. Izolat Mindanao je bio osjetljiv na 3 mg/kg diminazen diaceturata i kombinacije 
kvinapiramin sulfata i klorida, te 20 mg/kg izometamidij klorida. Može se reći da je diminazen bio učinkovit na 
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izolate s otoka Luzon, kvinapiramin na one s otoka Visayas, dok su diminazen ili kvinapiramin bili učinkoviti 
na izolate s otoka Mindanao. 
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